Friday, August 19, 2022 | Back issues
Courthouse News Service Courthouse News Service

Transgender Issues

BLS Pharma sued Inovio Pharmaceuticals and Genetronics for $77 million, claiming they refused to sell it proprietary elements of a needleless injector for testosterone injection after learning it would be used for transgender people, in Orange County Court.

SANTA ANA, Calif. — BLS Pharma sued Inovio Pharmaceuticals and Genetronics for $77 million, claiming they refused to sell it proprietary elements of a needleless injector for testosterone injection after learning it would be used for transgender people, in Orange County Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...